home All News open_in_new Full Article

India's Glenmark Pharma soars 10% to record high on AbbVie cancer treatment licensing deal

India's Glenmark Pharma soars 10% to record high on AbbVie cancer treatment licensing deal  Reuters


today 40 h. ago attach_file Politics

attach_file Politics
attach_file Events
attach_file Events
attach_file Politics
attach_file Science
attach_file Politics
attach_file Politics


ID: 2501830590
Add Watch Country

arrow_drop_down